For the survey, Reaction Data asked 133 directors of radiology, imaging directors and radiologists, among other stakeholders, about their attitudes toward machine learning, a type of artificial intelligence in which a computer learns over time, rather than having to be programmed like typical software.
Practicing radiologists were most “skeptical” of machine learning’s applicability and usability, while department leadership were more likely to perceive the technology as being “very important” to the medical imaging field, according to Reaction Data.
The three types of medical imaging participants were most likely to plan to use machine learning capabilities on were breast imaging (68 percent), lung imaging (61 percent) and chest X-rays (58 percent).
However, a minority of respondents (16 percent) reported they don’t ever think their department will use machine learning. Their reasons for hesitancy tended to focus on human clinicians being “better” than AI (46 percent), lack of “forward-thinking” leadership (39 percent) and uncertainty surrounding the usefulness of machine learning (15 percent).
To access Reaction Data’s survey, click here.
More articles on artificial intelligence:
Report: 3 reasons AI in healthcare is no longer just ‘hype’
51% of healthcare execs, IT leaders feel AI’s ‘disruption’ in the industry: 4 things to know
NTT Data partners with Pieces Technologies to integrate AI into clinical analytics portfolio
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
